一、主要会计数据和财务指标 | 名称 持有数量(万股) | | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 北京松安投资管理有限公司 | 3840.00 | 22.46 | 不变 | | 中庚价值先锋股票 | 633.45 | 3.71 | 280.37 | | 中庚价值领航混合 | 481.41 | 2.82 | 47.23 | | 易方达基金管理有限公司-社保基金17042组合 | 465.18 | 2.72 | 145.58 | | 毛顺华 | 317.95 | 1.86 | 新进 | | 北京富山湾投资管理中心(有限合伙) | 315.66 | 1.85 | 不变 | | 北京富宁湾投资管理中心(有限合伙) | 311.31 | 1.82 | 不变 | | 中庚价值品质一年持有期混合 | 293.55 | 1.72 | 10.00 | | 易方达新经济混合 | 243.31 | 1.42 | -70.45 | | 易方达科翔混合 | 241.08 | 1.41 | -99.28 | | 较上个报告期退出前十大股东有 | ...

Core Insights - The company reported a revenue of 1.23 billion yuan for 2024, with a net profit of 142 million yuan, marking a year-on-year growth of 22.18% [1] - In Q1 2025, the company achieved a revenue of 232 million yuan, reflecting an 8.90% year-on-year increase, and a net profit of approximately 25.67 million yuan, up 15.92% year-on-year [1] - The company maintained a high R&D investment intensity, with R&D expenditures of 157 million yuan in 2024, accounting for 12.79% of revenue, an increase of 0.57 percentage points year-on-year [1] R&D Progress - The company made significant advancements in several R&D projects during the reporting period, including the completion of Phase III clinical trials for KW-001 and the submission of a drug registration application [1] - KW-045 completed treatment and follow-up for all participants in its Phase IIa clinical trial for pediatric herpes pharyngitis [1] - KW-051 and KW-053 also progressed in their respective clinical trials, with KW-053 receiving approval for Phase II trials [1] Patent Activity - In 2024, the company applied for 9 invention patents and received authorization for 7, bringing the total to 175 applications and 60 authorized patents by the end of the reporting period [2] Capacity and Facility Upgrades - The company is advancing its antibody production base project, which has been included in Beijing's key engineering plans, with the main structure completed [3] - The company is upgrading its oral solid dosage production line and expanding capacity to accommodate future product launches [3] - The company is committed to enhancing its R&D capabilities and technical platform while focusing on innovative drug development and international collaboration [3]

中国经济网北京4月22日讯凯因科技(688687.SH)昨晚发布关于股东减持股份计划的公告显示，公司于近 日收到北京富山湾投资管理中心(有限合伙)(简称"富山湾")、北京富宁湾投资管理中心(有限合伙)(简 称"富宁湾")、北京卓尚石投资管理中心(有限合伙)(简称"卓尚石")、北京卓尚湾企业管理中心(有限合 伙)(简称"卓尚湾")出具的《股份减持计划告知函》。 富山湾、富宁湾、卓尚石、卓尚湾因其持有人自身资金需求，拟通过集中竞价及大宗交易的方式减持其 所持有的公司股份合计不超过5,128,000股，即不超过公司总股本的3.00%。自减持计划公告之日起15个 交易日后的3个月内(2025年5月16日至2025年8月15日)实施。 上述股份的减持价格均根据市场价格确定，若在减持计划实施期间公司发生派息、送股、资本公积转增 股本、配股等除权除息事项，将根据股本变动对减持数量进行相应调整。 公司实际控制人周德胜承诺不通过本次减持计划减持其间接持有的公司股份。 2024年2月3日，凯因科技发布以简易程序向特定对象发行人民币普通股股票预案。凯因科技本次以简易 程序向特定对象发行人民币普通股股票总额不超过人民币30,000. ...

Group 1 - UCM plans to reduce its holdings in Youde Precision (300549.SZ) by up to 1,333,400 shares, accounting for 1% of total share capital within three months after the announcement [1] - Dongtai Juheng plans to reduce its holdings in Jusa Long (301131.SZ) by up to 477,909 shares, also representing 1% of total share capital within the same timeframe [1] - Shouzhong Education intends to reduce its holdings in Jindan Technology (300829.SZ) by up to 600,000 shares, which is 0.31% of total share capital [1] Group 2 - Zhao Hua Investment plans to reduce its holdings in Zhidi Technology (301503.SZ) by up to 336,000 shares, accounting for 0.42% of total share capital [1] - Jinfu Yuan Five Fund's shareholding in Nanjiguang (300940.SZ) has dropped to 4.9999% as of April 21, no longer qualifying as a major shareholder [1] - Executives of Yashichuangneng (603378.SH) completed their reduction plans, selling 3,311,900 shares, 406,700 shares, and 319,300 shares respectively [1] Group 3 - Shanghai Houxu did not reduce its holdings in Baoli Food (603170.SH) during the planned reduction period, which was set to be up to 12,000,300 shares [2] - Supervisors and executives of Hongyuan Electronics (603267.SH) completed their reduction plans, selling 210,000 shares and 300,000 shares respectively [3] - Major shareholders of Duolun Technology (603528.SH) reduced their holdings by 3,055,000 shares and 3,056,400 shares between April 8 and April 21 [3] Group 4 - Controlling shareholder Ningbo Sichu reduced its holdings in Shuiyou Co., Ltd. (603171.SH) by 8,135,232 shares, which is 2% of total share capital [3] - Shareholders of Kaiyin Technology (688687.SH) plan to reduce their holdings by up to 5,128,000 shares, representing 3% of total share capital [3] - Zhang Lijun from Fortune Trend (688318.SH) reduced 122,800 shares, while Qin Tao did not implement his reduction plan [4] Group 5 - Shareholders Yancheng Semiconductor and Gongqingcheng Kangseng reduced their holdings in Kangxi Communication (688653.SH) by 12,573,400 shares, accounting for 2.96% of total share capital [4] - Ali Zeta plans to reduce its holdings in Sanjiang Shopping (601116.SH) by up to 16,430,352 shares, which is 3% of total share capital [4] - Shareholder Yuming Yao plans to reduce its holdings in Shenli Co., Ltd. (603819.SH) by up to 6,531,900 shares, representing 3% of total share capital [4] Group 6 - Shandong Electric Construction completed its reduction plan for Liren New Energy (001258.SZ), selling 9,333,300 shares, which is 1% of total share capital [6] - Baishide Chuangye plans to reduce its holdings in Heyuan Gas (002971.SZ) by up to 454,064 shares through centralized bidding and 908,128 shares through block trading [6]

证券代码：688687 证券简称：凯因科技 公告编号：2025-002 北京凯因科技股份有限公司 关于股东减持股份计划的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法 律责任。 重要内容提示： 股东持有的基本情况 截至本公告披露日，北京凯因科技股份有限公司（以下简称"公司"）股东： 北京富山湾投资管理中心（有限合伙）（以下简称"富山湾"）直接持有公司股份 3,156,600 股，占公司总股本的 1.85%；北京富宁湾投资管理中心（有限合伙） （以下简称"富宁湾"）直接持有公司股份 3,113,100 股，占公司总股本的 1.82%； 北京卓尚石投资管理中心（有限合伙）（以下简称"卓尚石"）直接持有公司股份 1,673,300 股，占公司总股本的 0.98%；北京卓尚湾企业管理中心（有限合伙） （以下简称"卓尚湾"）直接持有公司股份 1,043,922 股，占公司总股本的 0.61%。 富山湾、富宁湾、卓尚石、卓尚湾均属于公司实际控制人能够控制的企业，上述 股东合计持有公司股份 8,986,922 股，占公司总股本的 ...

凯因科技公告，股东富山湾、富宁湾、卓尚石、卓尚湾因持有人自身资金需求，计划通过集中竞价及大 宗交易方式减持公司股份不超过512.8万股，即不超过公司总股本的3.00%。减持期间为2025年5月16日 至2025年8月15日。减持价格将根据市场价格确定。 ...

Revenue Performance - Total revenue for 2024 was RMB 123,106.46 million, a decrease of 12.81% compared to the previous year[5] - The decline in total revenue was influenced by the implementation of centralized procurement policies for core products, leading to price reductions[5] Profitability - Net profit attributable to shareholders was RMB 14,383.47 million, an increase of 23.44% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 13,844.86 million, up 12.95% from the previous year[5] - Basic earnings per share increased to RMB 0.86, representing a growth of 22.86% compared to the previous year[3] - The weighted average return on equity rose to 8.01%, an increase of 1.20 percentage points[3] Assets and Equity - Total assets at the end of the reporting period were RMB 261,646.97 million, reflecting a year-on-year growth of 6.87%[5] - Shareholders' equity attributable to the parent company was RMB 184,471.26 million, an increase of 5.18% year-on-year[5] Cost Management - The company continued to promote cost reduction and efficiency enhancement strategies, resulting in a decrease in overall sales input ratio[5] Financial Stability - No financial data or indicators showed a change of 30% or more during the reporting period[6]

上 海 证 券 交 易 所 上证科创公监函〔2024〕0059 号 关于对北京凯因科技股份有限公司及有关责任 人予以监管警示的决定 定期报告是投资者关注的重大事项，可能对公司股价及投资者 决策产生影响，公司理应根据会计准则对当期财务数据进行客观、 谨慎地核算并披露。公司多期定期报告财务信息披露不准确等行为， 违反了《上海证券交易所科创板股票上市规则》（以下简称《科创板 股票上市规则》）第 5.1.2 条、第 5.1.4 条等有关规定。 1 责任人方面，公司时任董事长兼总经理周德胜作为公司主要负 责人、信息披露第一责任人，时任财务负责人郭伟作为公司财务事 项的具体负责人，根据《行政监管措施决定书》的认定，对公司相 关违规行为负有主要责任，违反了《科创板股票上市规则》第 4.2.1 条、第 4.2.4 条、第 4.2.5 条、第 5.1.2 条等规定及其在《董事（监 事、高级管理人员）声明及承诺书》中做出的承诺。 鉴于上述违规事实和情节，根据《科创板股票上市规则》第 14.2.1 条、第 14.2.2 条和《上海证券交易所纪律处分和监管措施实 施办法》等有关规定，我部作出如下监管措施决定： 对北京凯因科技股份有限 ...

根据《上市公司信息披露管理办法》（证监会令第182号）第五十一条、第五 十二条的规定，我局决定对你们采取责令改正的监管措施，并记入证券期货市场 诚信档案。你公司应该按照相关法律法规要求，提高财务核算规范化水平和信息 披露质量，依法履行信息披露义务，并于收到本决定书之日起15个工作日内向我 局报送书面整改报告。 如果对本监管措施不服，可以在收到本决定书之日起 60 日内向中国证券监 证券代码：688687 证券简称：凯因科技 公告编号：2024-055 北京凯因科技股份有限公司 关于收到《中国证券监督管理委员会北京监管局行政 监管措施决定书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京凯因科技股份有限公司于 2024 年 12 月 19 日收到中国证券监督管理委 员会北京监管局出具的《行政监管措施决定书》〔2024〕303 号，现将相关情况 公告如下： 一、《行政监管措施决定书》的主要内容 北京凯因科技股份有限公司、周德胜、郭伟： 经查，北京凯因科技股份有限公司（以下简称公司）存在以下问题：收入核 算管理不到 ...

凯因科技：收到北京监管局行政监管措施决定书 财联社12月19日电，凯因科技公告，公司于2024年12 月19日收到中国证券监督管理委员会北京监管局出具的《行政监管措施决定书》。 经查，公司存在收入核算管理不到位，2023年一季报、半年报、三季报存在收入跨期，相关信息披露不 准确等问题。 此外，还存在销售费用和营业成本核算管理不规范、关联方及关联交易披露不规范、对外捐赠相关非财 务信息披露不准确等问题。 北京监管局决定对公司及董事长周德胜、时任财务负责人郭伟采取责令改正的监管措施，并记入证券期 货市场诚信档案。 查看公告原文 ...